Amylyx Pharmaceuticals (AMLX) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of the board, executive team, and independent auditor representatives.

• Rules of conduct and procedures for submitting questions were outlined for participants.

• Notice of meeting and proxy materials were distributed to stockholders in accordance with bylaws.

Board and executive committee updates

• Board members and executive officers were introduced, including the Co-CEOs, CFO, and General Counsel.

• Deloitte & Touche LLP representatives were present as the independent registered public accounting firm.

Shareholder proposals

• Proposal one: Election of two Class II Directors to serve until the 2029 Annual Meeting.

• Proposal two: Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.

• Proposal three: Non-binding advisory vote to approve executive compensation.